High Prevalence of Non‐ BRCA Pathogenic Variants and a Recurrent PALB2 Variant in an Argentine Hereditary Breast and Ovarian Cancer Cohort
Cancer Medicine · 2026-04 · 15 (4)
DOI: 10.1002/cam4.71846 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 21.04.2026. Verfasst von Claudia Alejandra Martin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Privado Universitario de Córdoba, Córdoba, Argentina. Hauptthemen laut MEDLINE: Fanconi Anemia Complementation Group N Protein, Hereditary Breast and Ovarian Cancer Syndrome. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Hereditary breast and ovarian cancer (HBOC) syndromes are strongly associated with germline pathogenic variants. While genetic testing historically focused on BRCA1/2, multigene panels have revealed clinically relevant variants in numerous non‐BRCA genes. However, data on the spectrum and prevalence of these variants remain limited in Argentina, particularly in regions with distinctive admixture patterns. This study aimed to determine the frequency and spectrum of pathogenic and likely pathogenic variants (P/LPVs) in non‐BRCA genes among patients with a personal and/or family history of breast or ovarian cancer evaluated in Córdoba, Argentina. We conducted a retrospective analysis of 283 individuals tested within the Oncogenetics Program at Hospital Privado Universitario de Córdoba between 2016 and 2022 using multigene next‐generation sequencing panels and Sanger sequencing according to contemporary clinical criteria. P/LPVs were identified in 85 individuals (30.0%, 95% CI: 24.7–35.8), with non‐BRCA genes accounting for 32 P/LPVs (11.3%, 95% CI: 7.9–15.6 of the cohort). The most prevalent non‐BRCA genes were PALB2 (4.59%, 95% CI: 2.5–7.7) and CHEK2 (2.47%, 95% CI: 1.0–5.0), followed by TP53, MUTYH, and ATM. Notably, the PALB2 c.1653T>A variant was identified in five unrelated families, representing a recurrent variant compatible with a possible founder effect in this population. Overall, these findings highlight a substantial contribution of non‐BRCA P/LPVs—particularly PALB2—in this Córdoba‐based HBOC cohort. Post hoc analyses suggested sufficient statistical sensitivity to detect the observed differences; however, results should be interpreted considering the retrospective, single‐center design. These findings support the clinical value of incorporating non‐BRCA genes into multigene testing strategies in Argentina and underscore the need for larger multi‐center studies to confirm these observations and refine genetic counseling and surveillance strategies in Latin American populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital Privado Universitario de Córdoba, Córdoba, Argentina.
- Instituto Universitario de Ciencias Biomédicas de Córdoba (IUCBC), Córdoba, Argentina.
- Centro de Investigación en Medicina Traslacional "Severo R. Amuchástegui" (CIMETSA), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Córdoba, Argentina.
ORCID-Profile: Verónica Andreoli, Danilo Guillermo Ceschin
Zitieren
APA
Martin, C. A., Bono, C., Mandrile, J., Kunst, C. S. M., Borello, A. E., Ávila, R., Salazar, F. C., Miretti, V., Pabletich, F., Andreoli, V., & Ceschin, D. G. (2026). High Prevalence of Non‐ BRCA Pathogenic Variants and a Recurrent PALB2 Variant in an Argentine Hereditary Breast and Ovarian Cancer Cohort. Cancer Medicine, 15(4). https://doi.org/10.1002/cam4.71846
Vancouver
Martin CA, Bono C, Mandrile J, Kunst CSM, Borello AE, Ávila R, et al. High Prevalence of Non‐ BRCA Pathogenic Variants and a Recurrent PALB2 Variant in an Argentine Hereditary Breast and Ovarian Cancer Cohort. Cancer Medicine. 2026;15(4). doi:10.1002/cam4.71846
BibTeX
@article{Martin2026,
author = {Martin, Claudia Alejandra and Bono, Catalina and Mandrile, Juliana and Kunst, Christine Susana Mercedes and Borello, Adriana Elizabeth and Ávila, Rodolfo and Salazar, Florencia Celeste and Miretti, Virginia and Pabletich, Florencia and Andreoli, Verónica and Ceschin, Danilo Guillermo},
title = {High Prevalence of Non‐ BRCA Pathogenic Variants and a Recurrent PALB2 Variant in an Argentine Hereditary Breast and Ovarian Cancer Cohort},
journal = {Cancer Medicine},
year = {2026},
volume = {15},
number = {4},
doi = {10.1002/cam4.71846}
}
EUVIMED